Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/23191
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGilchrist, R.-
dc.contributor.authorRitter, L.-
dc.contributor.authorMyllymaa, S.-
dc.contributor.authorKaivo-Oja, N.-
dc.contributor.authorDragovic, R.-
dc.contributor.authorHickey, T.-
dc.contributor.authorRitvos, O.-
dc.contributor.authorMottershead, D.-
dc.date.issued2006-
dc.identifier.citationJournal of Cell Science, 2006; 119(18):3811-3821-
dc.identifier.issn0021-9533-
dc.identifier.issn1477-9137-
dc.identifier.urihttp://hdl.handle.net/2440/23191-
dc.descriptionCopyright © 2006 Company of Biologists-
dc.description.abstractOocytes regulate follicle growth by secreting paracrine growth factors that act on neighbouring granulosa cells (GCs). Those factors identified to date are mainly members of the transforming growth factor-ß (TGFß) superfamily, but little is known about which specific receptor/signalling system(s) they employ. This study was conducted to determine the requisite pathways utilised by oocytes to promote GC proliferation. We used an established oocyte-secreted mitogen bioassay, where denuded mouse oocytes are co-cultured with mural GCs. Oocytes, growth differentiation factor-9 (GDF9), TGFß1 and activin-A all promoted GC DNA synthesis, but bone-morphogenetic protein 6 (BMP6) did not. Subsequently, we tested the capacity of various TGFß superfamily receptor ectodomains (ECD) to neutralise oocyte- or specific growth factor-stimulated GC proliferation. The BMP type-II receptor (BMPR-II) ECD antagonised oocyte and GDF9 bioactivity dose-dependently, but had no or minimal effect on TGFß1 and activin-A bioactivity, demonstrating its specificity. The TGFßR-II, activinR-IIA and activinR-IIB ECDs all failed to neutralise oocyte- or GDF9-stimulated GC DNA synthesis, whereas they did antagonise the activity of their respective native ligands. An activin receptor-like kinase (ALK) 4/5/7 inhibitor, SB431542, also antagonised both oocyte and GDF9 bioactivity in a dose-dependent manner. Consistent with these findings, oocytes, GDF9 and TGFß1 all activated SMAD2/3 reporter constructs in transfected GC, and led to phosphorylation of SMAD2 proteins in treated cells. Surprisingly, oocytes did not activate the SMAD1/5/8 pathway in transfected GCs although exogenous BMP6 did. This study indicates that oocyte paracrine factors primarily utilise a similar signalling pathway first identified for GDF9 that employs an unusual combination of TGFß superfamily receptors, the BMPR-II and a SMAD2/3 stimulatory ALK (4, 5 or 7), for transmitting their mitogenic actions in GC. This cell-signalling pathway may also have relevance in the hypothalamic-pituitary axis and in germ-somatic cell interactions in the testis.-
dc.description.statementofresponsibilityRobert B. Gilchrist, Lesley J. Ritter, Samu Myllymaa, Noora Kaivo-Oja, Rebecca A. Dragovic, Theresa E. Hickey, Olli Ritvos and David G. Mottershead-
dc.language.isoen-
dc.publisherCompany of Biologists Ltd-
dc.source.urihttp://jcs.biologists.org/cgi/content/abstract/119/18/3811-
dc.subjectOocyte-paracrine factors-
dc.subjectGranulosa cell signalling-
dc.subjectGrowth-differentiation factor 9-
dc.subjectBone morphogenetic protein receptor-II-
dc.subjectActivin-receptor like kinase-
dc.subjectSMADs-
dc.subjectOocyte mitogen-
dc.titleMolecular basis of oocyte-paracrine signalling that promotes granulosa cell proliferation-
dc.typeJournal article-
dc.identifier.doi10.1242/jcs.03105-
pubs.publication-statusPublished-
dc.identifier.orcidGilchrist, R. [0000-0003-1611-7142]-
dc.identifier.orcidRitter, L. [0000-0001-5942-851X]-
dc.identifier.orcidHickey, T. [0000-0002-2752-730X]-
Appears in Collections:Aurora harvest 6
Obstetrics and Gynaecology publications

Files in This Item:
File Description SizeFormat 
hdl_23191.pdf410.56 kBPublisher's PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.